nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—Nicotinate metabolism—NMNAT1—age related macular degeneration	0.149	0.149	CbGpPWpGaD
Meloxicam—ABCC4—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.0817	0.0817	CbGpPWpGaD
Meloxicam—ABCC4—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.0728	0.0728	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—SERPING1—age related macular degeneration	0.0477	0.0477	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.0454	0.0454	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—ELOVL4—age related macular degeneration	0.0308	0.0308	CbGpPWpGaD
Meloxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT1—age related macular degeneration	0.0285	0.0285	CbGpPWpGaD
Meloxicam—PGD—NRF2 pathway—SQSTM1—age related macular degeneration	0.0264	0.0264	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0229	0.0229	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.0212	0.0212	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0182	0.0182	CbGpPWpGaD
Meloxicam—PTGS2—S1P1 pathway—KDR—age related macular degeneration	0.0174	0.0174	CbGpPWpGaD
Meloxicam—PGD—Disease—NMNAT1—age related macular degeneration	0.0152	0.0152	CbGpPWpGaD
Meloxicam—PGD—Disease—RDH8—age related macular degeneration	0.0152	0.0152	CbGpPWpGaD
Meloxicam—PGD—Disease—RPE65—age related macular degeneration	0.0133	0.0133	CbGpPWpGaD
Meloxicam—PGD—Metabolism—NMNAT1—age related macular degeneration	0.0127	0.0127	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—F13B—age related macular degeneration	0.0116	0.0116	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—CD36—age related macular degeneration	0.0114	0.0114	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ELOVL4—age related macular degeneration	0.0111	0.0111	CbGpPWpGaD
Meloxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.011	0.011	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SERPING1—age related macular degeneration	0.0109	0.0109	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.0109	0.0109	CbGpPWpGaD
Meloxicam—PGD—Disease—ABCA4—age related macular degeneration	0.0107	0.0107	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—SQSTM1—age related macular degeneration	0.0105	0.0105	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00994	0.00994	CbGpPWpGaD
Meloxicam—PTGS2—S1P1 pathway—VEGFA—age related macular degeneration	0.0096	0.0096	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—RAD51B—age related macular degeneration	0.00945	0.00945	CbGpPWpGaD
Meloxicam—PGD—Disease—RHO—age related macular degeneration	0.0093	0.0093	CbGpPWpGaD
Meloxicam—PGD—Metabolism—SLC16A8—age related macular degeneration	0.00895	0.00895	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SLC16A8—age related macular degeneration	0.00879	0.00879	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00854	0.00854	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00761	0.00761	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00761	0.00761	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00699	0.00699	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00671	0.00671	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00583	0.00583	CbGpPWpGaD
Meloxicam—PGD—Disease—CST3—age related macular degeneration	0.00581	0.00581	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00555	0.00555	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00552	0.00552	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—CCL2—age related macular degeneration	0.00547	0.00547	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—VEGFA—age related macular degeneration	0.00543	0.00543	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00533	0.00533	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00523	0.00523	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFBR1—age related macular degeneration	0.00522	0.00522	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00518	0.00518	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00506	0.00506	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00473	0.00473	CbGpPWpGaD
Meloxicam—PGD—Metabolism—LIPC—age related macular degeneration	0.00458	0.00458	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00452	0.00452	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CETP—age related macular degeneration	0.00442	0.00442	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00438	0.00438	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TLR4—age related macular degeneration	0.00404	0.00404	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00376	0.00376	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00368	0.00368	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NMNAT1—age related macular degeneration	0.00356	0.00356	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CCL2—age related macular degeneration	0.00347	0.00347	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RDH8—age related macular degeneration	0.00338	0.00338	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NMNAT1—age related macular degeneration	0.00338	0.00338	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ELOVL4—age related macular degeneration	0.00311	0.00311	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RPE65—age related macular degeneration	0.00295	0.00295	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00289	0.00289	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NMNAT1—age related macular degeneration	0.00283	0.00283	CbGpPWpGaD
Meloxicam—PGD—Disease—APOE—age related macular degeneration	0.0028	0.0028	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00278	0.00278	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CD36—age related macular degeneration	0.00266	0.00266	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CD36—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.00251	0.00251	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ELOVL4—age related macular degeneration	0.00247	0.00247	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00241	0.00241	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ABCA4—age related macular degeneration	0.00238	0.00238	CbGpPWpGaD
Meloxicam—PGD—Metabolism—APOE—age related macular degeneration	0.00234	0.00234	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.0023	0.0023	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00229	0.00229	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00221	0.00221	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RHO—age related macular degeneration	0.00207	0.00207	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.00201	0.00201	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC16A8—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00186	0.00186	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CST3—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—LIPC—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CETP—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFBR1—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—LIPC—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CETP—age related macular degeneration	0.000984	0.000984	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000954	0.000954	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00088	0.00088	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.00087	0.00087	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.00083	0.00083	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000801	0.000801	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000776	0.000776	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CD36—age related macular degeneration	0.000745	0.000745	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000676	0.000676	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOE—age related macular degeneration	0.000657	0.000657	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOE—age related macular degeneration	0.000623	0.000623	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CD36—age related macular degeneration	0.000592	0.000592	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOE—age related macular degeneration	0.000522	0.000522	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CD36—age related macular degeneration	0.000481	0.000481	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000446	0.000446	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CETP—age related macular degeneration	0.00043	0.00043	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000425	0.000425	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000392	0.000392	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000346	0.000346	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000258	0.000258	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
